Security Reports > Catabasis Pharmaceuticals

Catabasis Pharmaceuticals
Data Breaches, Cyber Attacks and Security Report  ᛫  Biotech & Pharmaceuticals
Last updated September 25, 2020

Catabasis Pharmaceuticals Security Rating

/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Catabasis Pharmaceuticals is implementing good security practices.

Company Information


About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals, founded in 2008 and based in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company. Catabasis’ SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables the company to engineer molecules that simultaneously modulate multiple targets in a disease.

Data Breaches and Security News

Security Report for Catabasis Pharmaceuticals

Want a security rating for your organization?

This report shows a preliminary security rating for Catabasis Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Catabasis Pharmaceuticals's security performance with other companies